Correction to: Improved Metabolic and Psychiatric Outcomes with Discontinuation of Atypical Antipsychotics in Youth Hospitalized in a State Psychiatric Facility by Hulvershorn L. et al. J Child Adolesc Psychopharmacol 2017;27:897–907. DOI: 10.1089/cap.2017.0040

In the December 2017 issue of the Journal of Child and Adolescent Psychopharmacology (vol. 27, no. 10; pages 897–907), in the article entitled, Improved Metabolic and Psychiatric Outcomes with Discontinuation of Atypical Antipsychotics in Youth Hospitalized in a State Psychiatric Facility by Hulvershorn et al., the mean age and age range of participants was miscalculated.

The mean age of participants and age range read as follows in the Abstract and in the Methods section.

“The study examined psychiatric and metabolic measures in 67 hospitalized children and adolescents (mean age 11.9; 56 with discontinued use of antipsychotics, 10 with continued use of antipsychotics, and 1 started on an antipsychotic) from admission to discharge.”

“The mean (±standard deviation [SD]) age of the sample was 11.90 years ±2.37 (range: 6–16 years); 31 (43.06%) were children (<12 years) and 41 (56.94%) were adolescents (≥12 years).”

The correct mean age and age range of participants should read as below.

“The study examined psychiatric and metabolic measures in 67 hospitalized children and adolescents (mean age 10.0 ; 56 with discontinued use of antipsychotics, 10 with continued use of antipsychotics, and 1 started on an antipsychotic) from admission to discharge.”

“The mean (±standard deviation [SD]) age of the sample was 10.0 years ±2.37 (range: 5–14 years); 52 (74.29%) were children (<12 years) and 18 (25.71%) were adolescents (≥12 years).”

The online version of the article has been corrected to reflect these changes. The authors apologize for the error.